$470M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | BMRN Biomarin Pharmaceutical Inc | 1.4M | +12.9% | $82M | 17.4% |
| 2 | GILD Gilead Sciences Inc | 343,043 | — | $43M | 9.2% |
| 3 | ARQT Arcutis Biotherapeutics Inc | 1.1M | — | $29M | 6.1% |
| 4 | MDGL Madrigal Pharmaceuticals Inc | 52,545 | — | $28M | 6.0% |
| 5 | BCAX Bicara Therapeutics Inc | 892,621 | −29.2% | $27M | 5.6% |
| 6 | RLMD Relmada Therapeutics Inc | 3.7M | +966.4% | $25M | 5.4% |
| 7 | TRVI Trevi Therapeutics Inc | 1.3M | +261.8% | $25M | 5.3% |
| 8 | PHVS Pharvaris N V | 677,879 | +305.9% | $23M | 5.0% |
| 9 | XENE Xenon Pharmaceuticals Inc | 367,900 | — | $22M | 4.7% |
| 10 | ANIP Ani Pharmaceuticals Inc | 233,808 | −26.6% | $19M | 4.1% |
| 11 | IMCR Immunocore Hldgs Plc | 512,856 | — | $16M | 3.5% |
| 12 | AMLX Amylyx Pharmaceuticals Inc | 894,058 | −44.1% | $16M | 3.4% |
| 13 | INSM Insmed Inc | 122,375 | — | $13M | 2.8% |
| 14 | NUVALENT INC Nuvalent Inc | 98,442 | −67.3% | $12M | 2.6% |
| 15 | CAPR Capricor Therapeutics Inc | 420,751 | −53.7% | $10M | 2.2% |
| 16 | ACRS Aclaris Therapeutics Inc | 1.8M | — | $9M | 2.0% |
| 17 | IMUX Immunic Inc | 539,814 | — | $8M | 1.8% |
| 18 | ORIC Oric Pharmaceuticals Inc | 747,313 | — | $8M | 1.7% |
| 19 | TNXP Tonix Pharmaceuticals Hldg C | 625,428 | +38.3% | $8M | 1.7% |
| 20 | SNDX Syndax Pharmaceuticals Inc | 340,000 | — | $7M | 1.6% |
| 21 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 574,166 | — | $7M | 1.5% |
| 22 | VIR Vir Biotechnology Inc | 659,213 | −45.0% | $7M | 1.4% |
| 23 | CRBP Corbus Pharmaceuticals Hldgs | 653,572 | — | $6M | 1.3% |
| 24 | DNTH Dianthus Therapeutics Inc | 57,100 | — | $6M | 1.2% |
| 25 | VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc | 11,123 | −89.8% | $6M | 1.2% |
| 26 | ELVN Enliven Therapeutics Inc | 49,850 | −91.6% | $3M | 0.5% |
| 27 | GPCR Structure Therapeutics Inc | 40,567 | −59.7% | $2M | 0.5% |
| 28 | PHAT Phathom Pharmaceuticals Inc | 161,486 | — | $2M | 0.4% |
| 29 | QUIT Achieve Life Science Inc | 26,760 | — | $174,743 | 0.0% |